Welcome to LookChem.com Sign In|Join Free

CAS

  • or

147034-01-3

Post Buying Request

147034-01-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

147034-01-3 Usage

General Description

(2,5-dibromophenyl)methanol is a chemical compound with the molecular formula C7H6Br2O. It is a white to light yellow solid that is used in various chemical reactions and as a building block for the synthesis of other compounds. This chemical is a brominated derivative of phenylmethanol and is commonly used in the pharmaceutical and agrochemical industries. It is a versatile compound that can undergo various chemical reactions to produce a wide range of derivatives, making it an important intermediate in organic synthesis. Additionally, it is used as a reagent in the preparation of various pharmaceuticals and other chemical products.

Check Digit Verification of cas no

The CAS Registry Mumber 147034-01-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,7,0,3 and 4 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 147034-01:
(8*1)+(7*4)+(6*7)+(5*0)+(4*3)+(3*4)+(2*0)+(1*1)=103
103 % 10 = 3
So 147034-01-3 is a valid CAS Registry Number.

147034-01-3Relevant articles and documents

Synthesis of 2,5-dibromobenzaldehyde and its reaction with hexylmagnesium bromide

Shimura,Kawai,Minegishi

, p. 43 - 44 (1993)

2,5-Dibromobenzaldehyde (3) is synthesized by the oxidation of 2,5-dibromotoluene (1) via 2,5-dibromobenzylidene diacetate (2). Grignard reaction of hexylmagnesium bromide with 2 gives the normal addition product, 2,5-dibromo-α-hexylbenzyl alcohol (5) and

ALDOSTERONE SYNTHASE INHIBITORS

-

Page/Page column 61, (2016/06/28)

The present invention relates to compounds of the formulas (IA) and (IB) and pharmaceutically acceptable salts thereof, wherein A and R1 - R6, are as defined herein. The invention also relates to pharmaceutical compositions comprisin

Aminopyridine-based c-Jun N-terminal kinase inhibitors with cellular activity and minimal cross-kinase activity

Szczepankiewicz, Bruce G.,Kosogof, Christi,Nelson, Lissa T. J.,Liu, Gang,Liu, Bo,Zhao, Hongyu,Serby, Michael D.,Xin, Zhili,Liu, Mei,Gum, Rebecca J.,Haasch, Deanna L.,Wang, Sanyi,Clampit, Jill E.,Johnson, Eric F.,Lubben, Thomas H.,Stashko, Michael A.,Olejniczak, Edward T.,Sun, Chaohong,Dorwin, Sarah A.,Haskins, Kristi,Abad-Zapatero, Cele,Fry, Elizabeth H.,Hutchins, Charles W.,Sham, Hing L.,Rondinone, Cristina M.,Trevillyan, James M.

, p. 3563 - 3580 (2007/10/03)

The c-Jun N-terminal kinases (JNK-1, -2, and -3) are members of the mitogen activated protein (MAP) kinase family of enzymes. They are activated in response to certain cytokines, as well as by cellular stresses including chemotoxins, peroxides, and irradiation. They have been implicated in the pathology of a variety of different diseases with an inflammatory component including asthma, stroke, Alzheimer's disease, and type 2 diabetes mellitus. In this work, high-throughput screening identified a JNK inhibitor with an excellent kinase selectivity profile. Using X-ray crystallography and biochemical screening to guide our lead optimization, we prepared compounds with inhibitory potencies in the low-double-digit nanomolar range, activity in whole cells, and pharmacokinetics suitable for in vivo use. The new compounds were over 1000-fold selective for JNK-1 and -2 over other MAP kinases including ERK2, p38α, and p38δ and showed little inhibitory activity against a panel of 74 kinases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 147034-01-3